Chronic spontaneous urticaria: Current approaches and the importance of awareness

Yıl 2025, Cilt: 3 Sayı: 3 , 158 - 159 , 29.10.2025

Melek Cihanbeylerden

https://doi.org/10.61845/agrimedical.1782782

https://izlik.org/JA72NB25FS

Öz

Since this manuscript is a letter to the editor, no abstract is required in accordance with the journal’s instructions for authors.

Anahtar Kelimeler

Angioedema , Antihistamine , Cyclosporine , Mast cell , Omalizumab , Urticaria

Etik Beyan

Bu çalışma için etik kurul onayı gerekmemektedir.

Kronik spontan ürtiker: Güncel yaklaşımlar ve farkındalığın önemi

https://izlik.org/JA72NB25FS

Öz

Bu makale editöre mektup niteliğindedir ve derginin yazarlara yönelik talimatları uyarınca özet gerektirmemektedir.

Anahtar Kelimeler

Anjioödem , Antihistaminik , Mast hücresi , Omalizumab , Siklosporin , Ürtiker

Etik Beyan

Bu çalışma için etik kurul onayı gerekmemektedir.

Kaynakça

• Kocatürk E, Chu DK, Türk M, et al. Management of chronic spontaneous urticaria made practical: what every clinician should know. J Allergy Clin Immunol Pract. 2025;13(9):2252-2269.
• Zuberbier T, Ensina LF, Giménez-Arnau A, et al. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalized treatment. Lancet. 2024;404(10450):393-404.
• Kolkhir P, Muñoz M, Asero R, et al. Autoimmune chronic spontaneous urticaria. J Allergy Clin Immunol. 2022;149(6):1819-31.
• Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766.
• Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133(5):1365-72.e6.
• Xiao X, Xue P, Shi Y, et al. The efficacy and safety of high-dose non-sedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials. BMC Pharmacol Toxicol. 2023;24(1):23.
• Maurer M, Rosén K, Hsieh H-J, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924-35.
• Soegiharto R, Aghdam MA, Sørensen JA, et al. Multinational drug survival study of omalizumab in patients with chronic urticaria and potential predictors for discontinuation. JAMA Dermatol. 2024;160(9):927-35.
• Türk M, Kocatürk E, Ertaş R, et al. A global perspective on stepping down chronic spontaneous urticaria treatment: results of the Urticaria Centers of Reference and Excellence SDown-CSU study. Clin Transl Allergy. 2024;14(2):e12343.
• Kulthanan K, Chaweekulrat P, Komoltri C, et al. Cyclosporine for chronic spontaneous urticaria: a meta-analysis and systematic review. J Allergy Clin Immunol Pract. 2018;6(2):586-99.